Status: Not yet recruiting
A Study of TPD3310 in Patients With Advanced Malignant Tumors
This study is a multicenter, open phase I clinical study of dose escalation,cohort expansion study to evaluate the safety,tolerability,pharmacokinetics,pharmacodynamics, and preliminary efficacy of TPD3310 in patients withadvanced malignant solid tumors.
Participants needed: 112
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.Updated: Jan 26, 2026Locations: 1
Eligibility criteria
Voluntarily sign the informed consent form and follow protocol requirements. [+15]
Curatively treated basal cell carcinoma of the skin, superficial bladder cancer,... [+31]